ArticleEuropean radiology2026
Predicting carotid in-stent restenosis with dual-energy CT: a multicenter study.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
objectivesOur work aimed to assess the clinical value of dual-energy computed tomography (DECT) parameters in predicting in-stent restenosis (ISR) after carotid artery stenting (CAS) and to develop a nomogram model incorporating these parameters to enhance the accuracy of ISR risk prediction. MATERIALS AND
methodsOur retrospective multicenter research enrolled 205 patients who underwent CAS from January 2018 to April 2023, with DECT scans performed prior to the procedure. Two radiologists independently measured the DECT parameters and evaluated the characteristics of carotid plaques. Univariate and multivariate analyses were conducted to identify independent predictors of ISR. Three models were developed: clinical model, DECT model, and nomogram model. These models were assessed based on the area under the curve (AUC) and calibration, with their clinical value assessed utilizing decision curve analysis (DCA).
resultsAmong 205 patients, 35 in the training set and 15 in the validation set experienced ISR. Multivariate analysis identified plaque length, fat fraction, normalized iodine concentration, and effective atomic number as independent predictors of ISR. Nomogram model, combining clinical and DECT parameters, demonstrated high accuracy in predicting ISR, with 0.931 (95% CI: 0.878-0.966) AUC in the training set and 0.872 (95% CI: 0.754-0.947) in the validation set, exceeding both clinical (AUC: 0.797, 0.673) and DECT models (AUC: 0.880, 0.853). Calibration curve and DCA exhibited the nomogram's excellent performance and clinical utility.
conclusionThe nomogram model integrating DECT parameters and clinical predictors provides a reliable and noninvasive tool for predicting ISR risk following CAS. It facilitates the formulation of individualized treatment strategies and offers important references for early intervention. KEY POINTS: Question Preoperative prediction of in-stent restenosis (ISR) risk after carotid artery stenting is critical for optimizing revascularization strategies, yet current assessment methods remain limited and subjective. Findings The nomogram incorporating plaque length, fat fraction, normalized iodine, and effective atomic number for predicting ISR risk achieved AUCs of 0.931 and 0.872 in the training and validation sets. Clinical relevance This nomogram can serve as an effective tool for predicting ISR risk to guide personalized treatment, potentially reducing ISR-related strokes and improving carotid stenting outcomes.
Indexed as
Identifiers
41198863What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.